Research Articles | Page 68 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort descending Bone Marrow Disease
Expression of nucleoside metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine Nov 2013 Leukemia myelodysplastic syndromes (MDS)
Distinct iron architecture in SF3B1 mutant myelodysplastic syndromes patients is linked to an SLC25A37 splice variant with a retained intron May 2014 Leukemia myelodysplastic syndromes (MDS)
Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders May 2012 Leukemia myelodysplastic syndromes (MDS)
Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes. Jun 2013 Leukemia myelodysplastic syndromes (MDS)
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes Nov 2016 Leukemia myelodysplastic syndromes (MDS)
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes Oct 2015 Leukemia myelodysplastic syndromes (MDS)
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Feb 2017 Leukemia myelodysplastic syndromes (MDS)
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system Oct 2015 Leukemia myelodysplastic syndromes (MDS)
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials Oct 2016 Leukemia myelodysplastic syndromes (MDS)